Those on the lowest dose (5 mg) of tirzepatide had lost an average of 15% of their body weight after one year and three months
Tirzepatide, a dual GIP/GLP-1 receptor agonist, has demonstrated greater efficacy in clinical trials, including the head-to-head SURMOUNT-5 trial comparing it to semaglutide 2.4 mg, potentially producing more substantial weight loss than traditional GLP-1 agonists alone
It can be really expensive to get services out of the primary network
Theres no one-size-fits-all method that everyone finds effective or lasting
So the honest answer isn't "yes" or "no." It's "it depends which drug, and even then, some of what you're seeing might just be what happens when anyone loses a lot of weight fast." Is "Lean Mass" the Same Thing as "Muscle"
High-dose intravenous Vitamin C has been shown to help reduce inflammation, support recovery from illnesses, and improve skin health